DOI

https://doi.org/10.25772/0BJE-3450

Defense Date

2023

Document Type

Dissertation

Degree Name

Doctor of Philosophy

Department

Microbiology & Immunology

First Advisor

Rebecca K. Martin

Abstract

Allergic asthma is among the most common respiratory diseases globally, affecting roughly 300 million people worldwide and causing significant morbidity and mortality. Initiation of allergic responses in asthma requires activation of a specialized subset of T follicular helper (Tfh) cells called Tfh13 cells. Tfh13 cell differentiation from naïve CD4+ T cells is induced by antigen presenting cells, such as conventional dendritic cells (cDCs), following allergen exposure. Allergen stimulation induces a distinct metabolic program in cDCs characterized by increased glutaminolysis which results in intracellular accumulation of α-ketoglutarate. Inhibition of glutaminolysis suppresses Tfh13 cell differentiation and promotes inhibitory T follicular regulatory (Tfr) cell activation in vivo. Further, glutamine-derived α-ketoglutarate was shown to promote epigenetic modifications via the Jumonji-domain containing (JmjC) family of histone demethylases, which are critical for DC activation and subsequent Tfh13 cell induction and IgE production. Indeed, JmjD3 blockade caused reduced Tfh13 and germinal center IgE. Finally, we show that glutaminase inhibitor treatment in allergen-sensitized mice induces allergen tolerance characterized by reduced asthmatic airway resistance, antigen-specific IgE production, and airway mast cell degranulation. Additionally, D-2-hydroxyglutarate, a metabolic by-product of α-ketoglutarate which acts as a competitive inhibitor of al JmjC enzymes, also suppresses Tfh13 and Th2 polarization while promoting Tfr induction. Thus, we demonstrate that α-ketoglutarate production via glutaminase is a critical enhancer of allergen-induced cDC activation and is crucial for induction of Tfh13 cells and antigen-specific IgE formation. Therefore, glutaminase and JmjD3 inhibitors promise to provide a new pharmacological strategy for controlling IgE-mediated allergic disease.

Rights

© Anuj Tharakan

Is Part Of

VCU University Archives

Is Part Of

VCU Theses and Dissertations

Date of Submission

5-1-2023

Available for download on Saturday, April 29, 2028

Share

COinS